ASAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.699800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.927000E-01
Normal-vs-Stage2
2.726000E-01
Normal-vs-Stage3
1.074030E-01
Normal-vs-Stage4
8.878000E-01
Stage1-vs-Stage2
7.928800E-01
Stage1-vs-Stage3
2.110000E-01
Stage1-vs-Stage4
4.464200E-01
Stage2-vs-Stage3
1.717200E-01
Stage2-vs-Stage4
3.537800E-01
Stage3-vs-Stage4
2.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.743000E-01
Normal-vs-AfricanAmerican
4.056600E-01
Normal-vs-Asian
1.410840E-01
Caucasian-vs-AfricanAmerican
9.126600E-01
Caucasian-vs-Asian
2.605600E-01
AfricanAmerican-vs-Asian
5.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.627800E-01
Normal-vs-Female
3.053400E-01
Male-vs-Female
4.357000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.399600E-01
Normal-vs-Age(41-60Yrs)
5.684400E-01
Normal-vs-Age(61-80Yrs)
2.035800E-01
Normal-vs-Age(81-100Yrs)
1.256810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.056200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.379000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.923000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.024150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.793700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.735190E-01
Normal-vs-Daily Drinker
6.679900E-02
Normal-vs-Weekly Drinker
4.268600E-01
Normal-vs-Occasional Drinker
5.492600E-01
Normal-vs-Social Drinker
6.695800E-01
Non Drinker-vs-Daily Drinker
5.845200E-01
Non Drinker-vs-Weekly Drinker
3.093200E-01
Non Drinker-vs-Occasional Drinker
2.584200E-01
Non Drinker-vs-Social Drinker
1.874790E-01
Daily Drinker-vs-Weekly Drinker
1.193600E-01
Daily Drinker-vs-Occasional Drinker
1.391620E-01
Daily Drinker-vs-Social Drinker
1.268800E-01
Weekly Drinker-vs-Occasional Drinker
9.072600E-01
Weekly Drinker-vs-Social Drinker
7.335200E-01
Occasional Drinker-vs-Social Drinker
8.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.497400E-01
Normal-vs-Grade 2
9.853600E-01
Normal-vs-Grade 3
9.257000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.538900E-03
Grade 1-vs-Grade 3
4.136400E-03
Grade 1-vs-Grade 4
8.497400E-01
Grade 2-vs-Grade 3
3.093400E-01
Grade 2-vs-Grade 4
9.853600E-01
Grade 3-vs-Grade 4
9.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.604600E-01
Normal-vs-NonDiabetic
2.225600E-01
Diabetic-vs-NonDiabetic
5.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.473410E-01
Normal-vs-NoPancreatitis
2.292400E-01
Pancreatitis-vs-NoPancreatitis
7.568600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.094600E-01
Normal-vs-N1
2.790400E-01
N0-vs-N1
6.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.928800E-01
Normal-vs-TP53-NonMutant
1.487560E-01
TP53-Mutant-vs-TP53-NonMutant
7.698400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
